Key words: attitude to health; clinical significance; cost-benefit analysis; decision making; minimal important difference; outcomes; patient preference; randomized controlled trials; research design; quality of life. (Med Decis Making XXXX; XX: xx–xx) Evidence-based medicine is built on a foundationof randomized trials. Interpretation of trials de-pends on whether a predetermined difference (effect size) between intervention and control groups was observed and the likelihood of this being due to chance (statistical significance). It is now generally agreed that the effect size for which a trial is pow-ered should be just large enough to be clinically sig-nificant. Introduction of the concept of minimal important difference (MID) in the 198...
It is important for clinicians and researchers to understand the effects of treatments on their pati...
Importance: The minimally important difference (MID) represents the point at which a difference in a...
This is a poster presented at the 6th International Clinical Trials Methodology Conference (ICTMC 20...
There is a long history of discussions about what is a minimal clinically important difference (MCID...
Over the past decades in modern medicine, there has been a shift from statistical significance to cl...
When assessing the clinical utility of therapies intended to improve subjective outcomes, the amount...
There is a long history of discussions about what is a minimal clinically important difference (MCID...
Artículo de publicación ISIIntroduction Patient-reported outcomes (PROs) are often the outcomes of g...
Introduction: Patient-reported outcomes (PROs) are often the outcomes of greatest importance to pati...
Abstract The evaluation and use of patient reported outcome (PRO) measures requires detailed underst...
The concept of a minimal clinically important difference (MCID) is well established. Here, we review...
UnrestrictedIntroduction: Minimally important differences (MIDs) are estimated to help interpret wha...
Abstract Recently, it was argued that clinically important differences should play no role in sample...
The concept of the minimal clinically important difference (MCID) is intended to provide a measure o...
Patient reported outcomes provide the patient's perspective on the effectiveness of treatment. The d...
It is important for clinicians and researchers to understand the effects of treatments on their pati...
Importance: The minimally important difference (MID) represents the point at which a difference in a...
This is a poster presented at the 6th International Clinical Trials Methodology Conference (ICTMC 20...
There is a long history of discussions about what is a minimal clinically important difference (MCID...
Over the past decades in modern medicine, there has been a shift from statistical significance to cl...
When assessing the clinical utility of therapies intended to improve subjective outcomes, the amount...
There is a long history of discussions about what is a minimal clinically important difference (MCID...
Artículo de publicación ISIIntroduction Patient-reported outcomes (PROs) are often the outcomes of g...
Introduction: Patient-reported outcomes (PROs) are often the outcomes of greatest importance to pati...
Abstract The evaluation and use of patient reported outcome (PRO) measures requires detailed underst...
The concept of a minimal clinically important difference (MCID) is well established. Here, we review...
UnrestrictedIntroduction: Minimally important differences (MIDs) are estimated to help interpret wha...
Abstract Recently, it was argued that clinically important differences should play no role in sample...
The concept of the minimal clinically important difference (MCID) is intended to provide a measure o...
Patient reported outcomes provide the patient's perspective on the effectiveness of treatment. The d...
It is important for clinicians and researchers to understand the effects of treatments on their pati...
Importance: The minimally important difference (MID) represents the point at which a difference in a...
This is a poster presented at the 6th International Clinical Trials Methodology Conference (ICTMC 20...